Model
Edge
Regeneron Pharmaceuticals, Inc.
0001681643
Filing Type
4
Filing Date
1/3/2024
Updated
1/4/24, 9:11 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership